Executive Summary
All five companies in this USA Trading Suspensions stream faced Nasdaq deficiency notices between April 15-17, 2026, signaling acute listing compliance risks with uniformly negative sentiment (100% negative across filings) and high materiality (9/10 average). Three firms (MBIO, ALBT, VRME) violated Rule 5550(a)(2) due to common stock closing below $1.00 for 30 consecutive business days (March 1-April 14/17 periods), while two (GITS, NKLR) breached Rule 5250(c)(1) via untimely 10-K filings for FY ended Dec 31, 2025. No immediate trading halts occurred, with grace periods extending to June 15 (compliance plans) and October 12-14, 2026 (full compliance), but failure risks delisting, appeals, or reverse splits. Absent enriched period-over-period financial trends or insider activity, the cluster highlights microcap distress patterns, potentially signaling broader small-cap liquidity/operational challenges amid no reported YoY revenue/margin data. Portfolio implication: elevated volatility and downside bias near catalyst dates, with 60-180 day windows for remediation but low success odds without capital raises.
Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from April 10, 2026.
Investment Signals(11)
- Global Interactive Technologies (GITS)(BEARISH)▲
Nasdaq notice for late 10-K filing (Rule 5250(c)(1)), 60-day plan deadline ~June 15, 2026, trading continues but signals operational delays vs peers
- Mustang Bio (MBIO)(BEARISH)▲
Stock below $1 for 30 consec days, 180-day grace to Oct 12, 2026, no guaranteed remedies despite monitoring intent
- Avalon GloboCare (ALBT)(BEARISH)▲
Closing bid < $1 for 30 days (Mar 1-Apr 14), 180-day period to Oct 12 vs peers' Oct 14 end, potential reverse split flagged
- VerifyMe (VRME)(BEARISH)▲
30-day sub-$1 close, slightly longer grace to Oct 14, 2026, eligibility for second period requires MVPH standards not met currently
- Terra Innovatum (NKLR)(BEARISH)▲
Late 10-K violation, plan due June 15 extendable to Oct 12, no immediate trading impact but mirrors GITS filing distress
- MBIO/ALBT/VRME(BEARISH)▲
3/5 companies share identical low-price deficiency (Rule 5550(a)(2)), 100% overlap in 30-day breach period, cluster risk amplification
- GITS/NKLR(BEARISH)▲
2/5 late filers both for Dec 31, 2025 10-K, no YoY filing trend data but signals reporting weakness vs compliant peers
- All 5(BEARISH)▲
Uniform negative sentiment, no bullish forward-looking beyond 'intent to comply', high materiality 9/10 average
- ALBT(BEARISH)▲
Explicit reverse split consideration, historically dilutive (no QoQ data), vs peers' vague remedies
- VRME(BEARISH)▲
Must notify intent for second grace, unmet initial standards currently, higher procedural risk vs MBIO/ALBT
- NKLR(BEARISH)▲
Global Select Market listing at risk, stricter standards than Capital Market peers, potential faster delisting path
Risk Flags(8)
- GITS/Delinquency[HIGH RISK]▼
Failed timely 10-K for FY2025, 60-day plan req'd, exposes unreported financials/operations, grace ends ~June 15
- MBIO/Low Price[HIGH RISK]▼
30 consec days < $1 (Rule 5550(a)(2)), 180-day clock to Oct 12, no success guarantee despite remedies exploration
- ALBT/Low Price[HIGH RISK]▼
Identical 30-day breach Mar1-Apr14, delisting path includes panel appeal but second period conditional on MVPH
- VRME/Compliance[HIGH RISK]▼
Sub-$1 for 30 days, Oct 14 deadline, second period needs listing standards + intent notice, procedural hurdles
- NKLR/Delinquency[HIGH RISK]▼
10-K late for FY2025, plan by June 15 or extend to Oct12, trading on higher-tier Global Select adds scrutiny
- Cluster/Low Price Trio[HIGH RISK]▼
MBIO/ALBT/VRME identical violation, synchronized Oct12-14 catalysts amplify sector contagion risk
- All/Appeal Dependency[MEDIUM-HIGH RISK]▼
Delisting stayed only by timely Hearings Panel request (Rule 5810(c)(3)(A)), unproven success rate
- No Enriched Financials[HIGH RISK]▼
Absent period trends (YoY/QoQ), ratios, or insiders flags deeper distress hidden in unreported 10-Ks
Opportunities(7)
- GITS/Compliance Plan(OPPORTUNITY)◆
Prompt 10-K filing + accepted plan could resolve by June15, trading continuity offers short-term hold for resolution
- MBIO/Reverse Split Potential(OPPORTUNITY)◆
Grace to Oct12, eligibility for second 180-day if MVPH met, could spark squeeze if executed
- ALBT/Turnaround(OPPORTUNITY)◆
180-day window + reverse split intent, Nasdaq Capital Market trading uninterrupted, monitor for capital infusion
- VRME/Second Period(OPPORTUNITY)◆
If meets initial standards post-Oct14, extended grace; authentication tech niche undervalued pre-compliance
- NKLR/Extension Path(OPPORTUNITY)◆
Plan acceptance extends to Oct12, Global Select retention premium if regained, watch for FY2025 disclosures
- Cluster/Short Squeeze(OPPORTUNITY)◆
3 low-price stocks with identical catalysts, reverse split adoption could drive volatility/rebound vs delist shorts
- All/Hearings Appeal(OPPORTUNITY)◆
Panel stay on delisting determination, historical reversals create binary upside for contrarians
Sector Themes(5)
- Microcap Price Deficiency Epidemic(BEARISH IMPLICATION)◆
3/5 (60%) hit sub-$1 for 30 days (Mar-Apr 2026), uniform 180-day graces to Oct, signals liquidity crunch in Nasdaq small caps
- Reporting Delays in Tech/Bio(BEARISH IMPLICATION)◆
2/5 late 10-Ks (GITS/NKLR), both FY2025 ends, potential operational strain absent YoY trends, contagion to unreporteds
- Synchronized Catalysts[RISK IMPLICATION]◆
100% grace periods converge June15 (plans)/Oct12-14 (compliance), heightens portfolio volatility for Nasdaq microcaps
- Remedy Uniformity(BEARISH IMPLICATION)◆
Reverse splits flagged (ALBT), vague 'intent to cure' across all, low capital alloc/insider conviction signals weak balance sheets
- No Bullish Enriched Data(BEARISH IMPLICATION)◆
Zero insider buys/guidance raises/capital returns, all negative sentiment clusters distress in bio/tech-adjacent names
Watch List(7)
- GITS/Compliance Plan👁
Submit plan within 60 days of Apr16 notice (~June15,2026), monitor 10-K filing for FY2025 financials reveal
- MBIO/Price Compliance👁
Track $1 close for 10 consec days by Oct12,2026; watch remedies like capital raise
- ALBT/Reverse Split👁
Announcement of split or other cure by Oct12, appeal potential if non-compliant
- VRME/Second Grace Eligibility👁
MVPH/initial standards check post-Oct14,2026; intent notice required
- NKLR/Plan Extension👁
June15,2026 plan submission, acceptance for Oct12 extension + 10-K drop
- All Trio (MBIO/ALBT/VRME)/Nasdaq Panel👁
Delisting notices trigger hearings requests, stay trading pending outcomes ~Oct2026
- Cluster/FY2025 10-Ks👁
GITS/NKLR filings to expose delayed metrics (revenue YoY, ratios), spillovers to price-deficient peers
Filing Analyses(5)
17-04-2026
On April 16, 2026, Global Interactive Technologies, Inc. received a Nasdaq Notification Letter for failing to timely file its Annual Report on Form 10-K for the year ended December 31, 2025, violating Nasdaq Listing Rule 5250(c)(1). The company has 60 calendar days from the notification date to submit a compliance plan and expects to file the overdue 10-K promptly to regain compliance. During this grace period, the company's common stock (GITS) will continue to trade on Nasdaq, subject to other listing requirements.
- ·Commission File Number: 001-41763
- ·I.R.S. Employer Identification No.: 88-1368281
- ·Principal executive offices: 160 Yeouiseo-ro, Yeongdeungpo-gu, Seoul, Republic of Korea 07231
- ·Registrant is an emerging growth company
17-04-2026
Mustang Bio, Inc. received a Nasdaq notice on April 15, 2026, stating non-compliance with Listing Rule 5550(a)(2) due to its common stock (MBIO) closing below $1.00 per share for 30 consecutive business days, with no immediate delisting effect. The company has a 180-calendar day grace period until October 12, 2026, to regain compliance by maintaining a $1.00 closing bid for at least 10 consecutive business days. Failure to comply risks delisting, though a potential second 180-day period or hearing may be available, and the company intends to monitor and explore remedies without guaranteed success.
- ·Compliance requires closing bid price of at least $1.00 per share for a minimum of ten consecutive business days (generally not more than 20) during the grace period.
- ·Eligibility for second 180-day period requires meeting initial listing criteria, continued listing for market value of publicly held shares, and written notice of intent to cure via reverse stock split if needed.
- ·Timely hearing request before Nasdaq Hearings Panel would stay delisting pending outcome.
17-04-2026
On April 15, 2026, Avalon GloboCare Corp. (ALBT) received a notification from Nasdaq indicating non-compliance with Listing Rule 5550(a)(2), as the closing bid price of its common stock fell below the $1.00 per share minimum for 30 consecutive business days from March 1 to April 14, 2026. The Company has 180 calendar days until October 12, 2026, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days, with trading continuing uninterrupted on Nasdaq Capital Market under 'ALBT'. Failure to comply could lead to a potential second 180-day period or delisting, and the Company may pursue a reverse stock split.
- ·Nasdaq Listing Rule 5810(c)(3)(A) defines the 30 consecutive business day deficiency period.
- ·Potential second 180-day compliance period available if market value of publicly-held shares and other initial listing standards are met.
- ·Company will have appeal opportunity to a Hearings Panel if delisting determination is issued.
17-04-2026
On April 17, 2026, VerifyMe, Inc. (VRME) received a notification from Nasdaq indicating that its common stock failed to satisfy Nasdaq Listing Rule 5550(a)(2) due to a closing bid price below $1 per share for 30 consecutive business days. The company has a 180-calendar-day compliance period until October 14, 2026, to regain compliance by achieving at least a $1 closing bid price for 10 consecutive business days, with no immediate effect on its Nasdaq listing. Failure to comply could lead to delisting, though the company may qualify for a second compliance period or appeal to a Nasdaq Hearings Panel.
- ·Nasdaq Listing Rule 5810(c)(3)(A) governs the 180-day compliance period.
- ·Company may be eligible for a second 180-day period if it meets market value of publicly held shares and other initial listing standards for Nasdaq Capital Market.
- ·Company must notify Nasdaq of intent to cure the deficiency for second period eligibility.
- ·Common stock par value: $0.001 per share; traded as VRME on The Nasdaq Capital Market.
17-04-2026
Terra Innovatum Global N.V. (NKLR) received a Nasdaq deficiency notice on April 16, 2026, for failing to timely file its Form 10-K for the fiscal year ended December 31, 2025, violating Nasdaq Listing Rule 5250(c)(1). The notice has no immediate effect on the listing or trading of its ordinary shares on Nasdaq Global Select Market, but the company must submit a compliance plan by June 15, 2026, with potential extension to October 12, 2026, if accepted. The company intends to regain compliance as soon as practicable.
- ·Trading symbol: NKLR
- ·Commission File Number: 001-42901
- ·Fiscal year end: December 31
- ·Emerging growth company: Yes
Get daily alerts with 11 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 5 filings
More from: US SEC Trading Suspension Halt Orders
🇺🇸 More from United States
View all →April 10, 2026
US Pre-Market SEC Filings Roundup — April 10, 2026
US Pre-Market SEC Filings Roundup
April 10, 2026
US Merger & Acquisition SEC Filings — April 10, 2026
US Merger & Acquisition SEC Filings
April 10, 2026
US Corporate Board Director Changes SEC Filings — April 10, 2026
US Corporate Board Director Changes SEC Filings
April 10, 2026
US Executive Officer Management Changes SEC — April 10, 2026
US Executive Officer Management Changes SEC